Latest Business Development News

Yojee enters FY27 with 12 signed MOSAIC customer agreements and $10.45 million in fresh funding, but the freight software company is still loss-making and yet to generate meaningful MOSAIC revenue. Management expects initial billings in the December quarter as it works to convert signed customers into live, billable usage.

Apollo Minerals ended 2026 with A$7.74 million in cash and no debt after raising A$9.3 million, but remains a loss-making explorer with no JORC Mineral Resources or production. The company is now concentrating its exploration story on the reinstated Couflens tungsten-gold project in France, while carrying a conceptual zinc-lead target in Gabon.

XPON Technologies has completed the sale of Datisan to Incubeta Australia, securing $8.1 million in cash and potential additional earn-out consideration of up to A$2 million. The transaction leaves XPON focused on its Wondaris AI Marketing Platform and AI-sector acquisitions.

AnteoTech has set sales conversion as its FY2027 priority after FY2026 sales revenue slipped to A$460,397, while operating expenses fell sharply and cash stood at A$11.2 million. The battery materials and life sciences company says customer evaluations and partnership discussions are building, but most opportunities remain short of recurring commercial revenue.

Rhythm Biosciences has moved ColoSTAT and geneType into commercial use, recording its first sales during FY2026. But with sales revenue of just $85,339, a $5.93 million loss and an auditor-flagged going-concern uncertainty, the next phase will be judged on cash generation and repeat adoption.

Firebrick Pharma has approved a phased push into US retail pharmacies after Nasodine online sales grew by more than 200% in FY26. Up to six regional pharmacy groups representing about 700 stores have expressed strong interest in early orders, although no binding orders have been disclosed.

Embelton Limited (ASX:EMB) grew revenue, profit and operating cash flow in FY2026 despite subdued residential construction, while maintaining its 35-cent fully franked annual dividend. The flooring and engineering group is leaning further into infrastructure, data centres, healthcare and other commercial work, although its near-term contracting pipeline remains modest.

NGX Limited (ASX:NGX) has warned of a material uncertainty over its ability to continue as a going concern after cash reserves fell to A$1.65 million. The minerals explorer says it will need additional working capital through September 2027, despite advancing graphite, rutile and uranium projects.

AnteoTech reduced its FY2026 loss and strengthened its balance sheet, but auditors warned that a material uncertainty remains over the company’s ability to continue as a going concern. Commercial revenue fell sharply as battery and diagnostics opportunities remained largely in evaluation or negotiation.

PainChek grew recurring revenue, implemented licences and customer sites in FY2026, but its $8.94 million loss and $9.24 million operating cash outflow prompted an explicit going-concern warning from its auditor. The company is now betting that US deployments and a sharper commercial focus can convert market access into cash-generating growth.

Silver Mines has secured firm commitments for a $70 million placement, giving the company more funding to advance its Bowdens Silver Project through development approvals and engineering studies. The raise also supports royalty acquisitions, exploration and land access, although nearly 43% of the new shares still require shareholder approval.

Platina Resources has reshaped itself around a 312 square kilometre gold portfolio in Western Australia’s Laverton district, backed by $8.61 million in cash. The FY2026 annual report shows stronger exploration momentum, but the company remains loss-making and dependent on turning targets into discoveries.